Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of new peer-reviewed research in The Journal of Clinical Psychiatry demonstrating how the Tardive Dyskinesia Impact Scale ...

Among more than 2,000 patients who completed a TDScreen assessment, 156 received a Tardive Dyskinesia diagnosis and 125 were prescribed treatment, real-world evidence that AI-enabled screening is ...

Tardive dyskinesia (TD) is a side effect of antipsychotic or neuroleptic medications that causes involuntary movements of the face, neck, arms, and legs. These movements can affect social life, ...

Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of exposure to neuroleptic medications," said Jeff Bronstein, MD, PhD, of the ...

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

Tardive dyskinesia causes repeated, uncontrollable movements in the face and body. It is a side effect of some neuroleptic or antipsychotic medications. These medications may change dopamine activity ...

Awareness Week (May 3-9, 2026) brings attention to TD and aims to reduce stigma and support those affected by the condition. This important week unites ...

Tardive dyskinesia is a common side effect caused by antipsychotic use. It is a neurological disorder characterized by involuntary, repetitive movements, often involving the face, mouth, tongue, and ...

Please provide your email address to receive an email when new articles are posted on . Once-daily valbenazine, a selective vesicular monoamine transporter 2 inhibitor, significantly improved tardive ...

LONDON--(BUSINESS WIRE)--The global tardive dyskinesia treatment market 2019-2023 is expected to post a CAGR of more than 4% during the forecast period, according to the latest market research report ...

Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...